IQST - EV & Hi-Tech Company Poised For Potential 4X ROI - Q3 Financials and Short Squeeze
14 Ottobre 2021 - 5:34PM
InvestorsHub NewsWire
October 14, 2021 -- InvestorsHub NewsWire -- via
pennymillions --
iQSTEL, Inc. (OTCQX:
IQST) is on track to meet a $60.5 million annual revenue
forecast. The upcoming Q3 report could be a trigger to
catapult the stock from its plus or minus $0.50 price back to its
well deserved $2.00 52 week high delivering a 4X
ROI.
IQST Q to Q Revenue In Millions
The
company has been growing its topline quarter-to-quarter and the
upcoming Q3 financial report is likely to show another
quarter-to-quarter revenue expansion in addition to a further
validation of the $60.5 million annual revenue forecast being in
reach.
Perfect Storm – EV Market Entry, Q3 Financials
and Short Squeeze
IQST is on the verge of making its Electric
Vehicle (EV) market debut with the delivery of its first batch of
electric motorcycles into South America.
IQST –
iQSTEL Releases Sneak Peek Of EVOSS Electric Motorcycle Deploying
Soon (Video)
As
crazy as it sounds with consistent quarter-to-quarter growth and
the impending Q3 report on the horizon combined with the imminent
entry into the red-hot EV market, someone is hedging against IQST’s
ongoing performance. Recent trading has seen consistent short
selling with nearly half of the daily volume being reported by
FINRA as short sales.
A
consistent Q3 report + EV Entry + Short Squeeze = A Potential Rally
Back To $2.00
Source - https://www.pennymillions.com/blog/jvo1l3avbnicptdciuc3yoad8ptxqv
Other stocks on the move include
AMBL,
ALPP and
NWBO.
SOURCE: pennymillions
Grafico Azioni Northwest Biotherapeutics (QB) (USOTC:NWBO)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Northwest Biotherapeutics (QB) (USOTC:NWBO)
Storico
Da Mag 2023 a Mag 2024
Notizie in Tempo Reale relative a Northwest Biotherapeutics Inc (QB) (OTCMarkets): 0 articoli recenti
Più Northwest Biotherapeutics Inc (QB) Articoli Notizie